K
Kuria Therapeutics develops novel therapeutics to preserve vision and treat ophthalmic diseases rooted in mitochondrial dysfunction and oxidative stress. The company focuses on developing product candidates that leverage the body's defense system to strengthen and repair damaged corneal cells. Their approach aims to improve vision for patients with conditions like Fuchs' Dystrophy and protect corneal integrity following eye surgery.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Kuria Therapeutics develops novel therapeutics to preserve vision and treat ophthalmic diseases rooted in mitochondrial dysfunction and oxidative stress. The company focuses on developing product candidates that leverage the body's defense system to strengthen and repair damaged corneal cells. This approach aims to improve vision for patients with conditions like Fuchs' Dystrophy and protect against vision threats from eye surgery or chronic conditions.